Subject: Conference Calls/ Webcasts
Stemtech Corporation to Webcast Live at VirtualInvestorConferences.com August 4th
MIRAMAR, Fla., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (OTCQB:STEK), based in Florida, focused on stem cell nutrition, anti-aging, wellness and income earning opportunities, today announced that John W. Meyer, President & COO, will present live at VirtualInvestorConferences.com on August 4th, 2022.
DATE: August 4th, 2022
TIME: 1 p.m. Eastern
LINK: https://bit.ly/3u8UbFn
Available for 1x1 meetings: August 5, 6 & 7
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Recent Company Highlights
- Stemtech Corporation partners with verb in launching interactive video and livestreaming sales enablement apps to strengthen direct sales channel
- Stemtech Corporation elevates network marketing hall of famer Izzy Matos to founding independent business partner
- Stemtech Corporation increases independent business partner (ibp) recruiting by 38% during recent enrollment period
About Stemtech
Stemtech Corporation, a leading nutraceutical company with a direct sales distribution model, was founded on April 18, 2018, after acquiring the operations from its predecessor Stemtech International, Inc. which was founded in 2005. From 2010 through 2015, Stemtech International, Inc., was recognized four separate times on the Inc. 5000 Fastest-Growing Companies list. In 2018, the Company underwent an extensive executive reorganization, and continued operations under new leadership. Stemtech specializes in creating products and formulas that are patent protected in the U.S. and in select international markets. The Company's patented formulas help the release, circulation and migration of the body's adult stem cells from its bone marrow. The Company markets its products under the following brands: RCM System, stemrelease3tm, Stemflo® MigraStem, OraStem® (Oral Health Care), and D-Fuzetm (EMF blocker). Its products are all-natural and plant-based and manufactured under cGMP (Current Good Manufacturing Practices) under the auspices of the Dietary Supplement Health and Education Act (DSHEA). For more information, please visit www.stemtech.com.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
| CONTACTS: | ||
| Stemtech Corporation | ||
| Name: | Frank J. Pena | |
| Title: | Investor Relations | |
| Phone: | 908-675-0581 | |
| Email: | [email protected] | |
Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
[email protected]
These press releases may also interest you
|
News published on and distributed by:
